Document Detail


Lacidipine and blood pressure variability in diabetic hypertensive patients.
MedLine Citation:
PMID:  11040246     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The aim of our study was to assess the effects of lacidipine, a long-acting calcium antagonist, on 24-hour average blood pressure, blood pressure variability, and baroreflex sensitivity. In 10 mildly to moderately hypertensive patients with type II diabetes mellitus (aged 18 to 65 years), 24-hour ambulatory blood pressure was continuously monitored noninvasively (Portapres device) after a 3-week pretreatment with placebo and a subsequent 4-week once daily lacidipine (4 mg) or placebo treatment (double-blind crossover design). Systolic blood pressure, diastolic blood pressure, and heart rate means were computed each hour for 24 hours (day and night) at the end of each treatment period. Similar assessments were also made for blood pressure and heart rate variability (standard deviation and variation coefficient) and for 24-hour baroreflex sensitivity, which was quantified (1) in the time domain by the slope of the spontaneous sequences characterized by progressive increases or reductions of systolic blood pressure and RR interval and (2) in the frequency domain by the squared ratio of RR interval and systolic blood pressure spectral power approximately 0.1 and 0.3 Hz over the 24 hours. Compared with placebo, lacidipine reduced the 24-hour, daytime, and nighttime systolic and diastolic blood pressure (P<0.05) with no significant change in heart rate. It also reduced 24-hour, daytime, and nighttime standard deviation (-19.6%, -14.4%, and -24.0%, respectively; P<0.05) and their variation coefficient. The 24-hour average slope of all sequences (7.7+/-1.7 ms/mm Hg) seen during placebo was significantly increased by lacidipine (8.7+/-1.8 ms/mm Hg, P<0.01), with a significant increase being obtained also for the 24-hour average alpha coefficient at 0.1 Hz (from 5.7+/-1.5 to 6.4+/-1.3 ms/mm Hg, P<0.01). Thus, in diabetic hypertensive patients, lacidipine reduced not only 24-hour blood pressure means but also blood pressure variability. This reduction was accompanied by an improvement of baroreflex sensitivity. Computer analysis of beat-to-beat 24-hour noninvasive blood pressure monitoring may offer valuable information about the effects of antihypertensive drugs on hemodynamic and autonomic parameters in daily life.
Authors:
A Frattola; G Parati; P Castiglioni; F Paleari; L Ulian; G Rovaris; G Mauri; M Di Rienzo; G Mancia
Related Documents :
8067416 - Cardiovascular regulation in humans in response to oscillatory lower body negative pres...
15878556 - Improvement in sympatho-vagal imbalance and heart rate variability in patients with mit...
21449996 - Serum uric acid levels correlate with filling pressures in systolic heart failure.
18024546 - Clinical correlates of frequency analyses of cardiovascular control after spinal cord i...
10965376 - Maximal oxygen uptake, muscle strength and walking speed in 85-year-old women: effects ...
1192566 - Chronic one-kidney hypertension in rabbits. i. treatment with kidney extracts.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Hypertension     Volume:  36     ISSN:  1524-4563     ISO Abbreviation:  Hypertension     Publication Date:  2000 Oct 
Date Detail:
Created Date:  2000-10-25     Completed Date:  2000-11-21     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7906255     Medline TA:  Hypertension     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  622-8     Citation Subset:  IM    
Affiliation:
Clinica Medica, University of Milano-Bicocca and Ospedale S. Gerardo, Monza, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antihypertensive Agents / administration & dosage*
Baroreflex / drug effects
Blood Pressure / drug effects*
Blood Pressure Monitoring, Ambulatory
Calcium Channel Blockers / administration & dosage
Circadian Rhythm
Cross-Over Studies
Diabetes Complications*
Dihydropyridines / administration & dosage*
Double-Blind Method
Electrocardiography / drug effects
Female
Heart Rate / drug effects
Humans
Hypertension / complications,  drug therapy*,  physiopathology
Male
Middle Aged
Reproducibility of Results
Signal Processing, Computer-Assisted
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 0/Calcium Channel Blockers; 0/Dihydropyridines; 103890-78-4/lacidipine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Angiotensin II stimulates extracellular signal-regulated kinase activity in intact pressurized rat m...
Next Document:  Proximal sodium reabsorption: An independent determinant of blood pressure response to salt.